47 related articles for article (PubMed ID: 33277447)
1. Incidence and Risk Factors of Post-renal Transplantation Malignancies in North of Iran, A 20-year Experience.
Nejatifar F; Monfared A; Khosravi M; Lebadi M; Shakiba M; Mokhtari G; Aghajanzadeh P; Haghdar-Saheli Y; Movasaghi A; Ramezanzadeh E; Akhondzadeh L
Iran J Kidney Dis; 2020 Dec; 14(6):439-447. PubMed ID: 33277447
[TBL] [Abstract][Full Text] [Related]
2. Incidence of
Srisuwarn P; Sutharattanapong N; Disthabanchong S; Kantachuvesiri S; Kitiyakara C; Phakdeekitcharoen B; Ingsathit A; Sumethkul V
Transpl Int; 2024; 37():11614. PubMed ID: 38468637
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
Lu K; Chiu KY
Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
[TBL] [Abstract][Full Text] [Related]
4. Cancer incidence in kidney transplant recipients: a study protocol.
Pita-Fernandez S; Valdes-Cañedo F; Pertega-Diaz S; Seoane-Pillado MT; Seijo-Bestilleiro R
BMC Cancer; 2009 Aug; 9():294. PubMed ID: 19698143
[TBL] [Abstract][Full Text] [Related]
5. Post Renal Transplant Malignancies; A Basic Concept.
Nabi Z; Zahid T; Nabi R
J Ayub Med Coll Abbottabad; 2023; 35(4):664-668. PubMed ID: 38406957
[TBL] [Abstract][Full Text] [Related]
6. Post renal-transplant malignancy surveillance.
Manickavasagar R; Thuraisingham R
Clin Med (Lond); 2020 Mar; 20(2):142-145. PubMed ID: 32188647
[TBL] [Abstract][Full Text] [Related]
7. An analysis of iris pattern as a risk factor for skin cancer development in immunosuppressed renal transplant recipients.
Leahy M; Griffin L; Prendergast G; Griffin M; Laing M
J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):311-314. PubMed ID: 37590547
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcomes for the development of malignancy in lung and heart-lung transplant recipients.
Metcalfe MJ; Kutsogiannis DJ; Jackson K; Oreopoulous A; Mullen J; Modry D; Weinkauf J; Lien DC; Stewart KC
Can Respir J; 2010; 17(1):e7-13. PubMed ID: 20186364
[TBL] [Abstract][Full Text] [Related]
9. Incidence of malignancies after lung transplantation and their effect on the outcome. 26 years' experience.
Spetsotaki K; Koch A; Taube C; Theegarten D; Kamler M; Pizanis N
Heliyon; 2023 Oct; 9(10):e20592. PubMed ID: 37810874
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network.
Sprangers B; Nair V; Launay-Vacher V; Riella LV; Jhaveri KD
Clin Kidney J; 2018 Jun; 11(3):315-329. PubMed ID: 29942495
[TBL] [Abstract][Full Text] [Related]
11. Early Results of a Screening Program for Skin Cancer in Liver Transplant Recipients: A Cohort Study.
Akdag D; Rasmussen A; Nielsen SD; Møller DL; Togsverd-Bo K; Wenande E; Haedersdal M; Pommergaard HC
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539557
[TBL] [Abstract][Full Text] [Related]
12. Photoprotection and skin cancer education: the experiences of renal transplant recipients, a qualitative study - why the 'personal touch' is important.
Griffin L; O'Reilly P; Murphy M; Prendergast G; Pender E; Tummon O; Griffin M; Laing M
Br J Dermatol; 2023 Jul; 189(1):145-147. PubMed ID: 37022792
[No Abstract] [Full Text] [Related]
13. Overall of kidney transplant recipients with a pretransplantation cancer history.
Chargui S; Braiek N; Bacha MM; Harzallah A; Hedri H; Ouinissi M; Abderrahim E
Clin Case Rep; 2021 Sep; 9(9):e04810. PubMed ID: 34532051
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet radiation manicure-related keratinocyte malignancies in a renal transplant recipient.
Kearney N; Stefanovic N; Roche M
Lancet; 2024 Jan; 403(10421):e1. PubMed ID: 38184337
[No Abstract] [Full Text] [Related]
15. Comparison Between eGFR by Schwartz Formula with Measured GFR by Radionuclide Diethylenetriamine Pentaacetic Acid Scan (Tc99 DTPA scan), in Patients Undergoing Chemotherapy with Nephrotoxic Drugs.
Esmaeilnejad SS; Nazari S; Esfandiar N
Iran J Kidney Dis; 2020 Dec; 14(6):463-469. PubMed ID: 33277450
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced ocular inflammation.
Samalia P; Sims J; Niederer R
N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
[TBL] [Abstract][Full Text] [Related]
17. Defined Daily Dose and Appropriateness of Clinical Application: The Coxibs and Traditional Nonsteroidal Anti-Inflammatory Drugs for Postoperative Orthopaedics Pain Control in a Private Hospital in Malaysia.
Bakrin FS; Makmor-Bakry M; Che Hon WH; Faizal SM; Manan MM; Ming LC
Pharmacy (Basel); 2020 Dec; 8(4):. PubMed ID: 33302438
[TBL] [Abstract][Full Text] [Related]
18. Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer.
Zhou L; Xu Q; Huang L; Jin J; Zuo X; Zhang Q; Ye L; Zhu S; Zhan P; Ren J; Lv T; Song Y
Cancer Lett; 2021 Mar; 500():163-171. PubMed ID: 33278498
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine Induced Massive Ascites, a Rare Clinical Case.
Arasan SN; Yenigun EC; Cevher SK; Dede F
Iran J Kidney Dis; 2020 Dec; 14(6):517-519. PubMed ID: 33277458
[TBL] [Abstract][Full Text] [Related]
20. Association of Metabolic Syndrome and Asthma Status: A Prospective Study from Guilan Province, Iran.
Nejatifar F; Foumani AA; Poor ARG; Nejad AT
Endocr Metab Immune Disord Drug Targets; 2022; 22(4):395-400. PubMed ID: 33676392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
